Related Experiment Video
Updated: Aug 8, 2026
06:40
The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
Published on: June 29, 2019
[Chronic gastritis: last decade's achievements and problems]
Klinicheskaia Meditsina
|March 12, 2005
Summary
Recent classifications standardize chronic gastritis and gastric disease diagnosis. Eradicating Helicobacter pylori can reverse gastritis, and non-invasive tests aid atrophic gastritis detection, paving the way for gastric cancer prevention.
Area of Science:
- Gastroenterology
- Pathology
- Oncology
Background:
- Standardized classifications (e.g., Sidney, Vienna) improve international research and diagnostics of gastric mucosal changes.
- Helicobacter pylori eradication can reverse morphological changes in chronic gastritis.
- Long-term proton pump inhibitor (PPI) use does not cause atrophic gastritis after successful H. pylori eradication but can intensify corporal gastritis.
Purpose of the Study:
- To review recent advancements in the classification, diagnosis, and treatment of chronic gastritis and related gastric diseases.
- To highlight the impact of Helicobacter pylori eradication on gastritis morphology.
- To discuss the role of serological markers in diagnosing atrophic gastritis and the implications of PPI therapy.
Main Methods:
- Review of recent international classifications for gastric diseases.
- Analysis of studies on Helicobacter pylori eradication effects on gastritis.
- Evaluation of non-invasive serological diagnostic methods for atrophic gastritis.
- Assessment of long-term proton pump inhibitor therapy effects.
Main Results:
- Standardized classifications enable objective diagnostics and international research collaboration.
- Successful H. pylori eradication leads to reduced morphological manifestations of chronic gastritis.
- Serum levels of H. pylori antibodies, gastrin, and pepsinogen I/II offer non-invasive serological diagnostics for atrophic gastritis.
- While not causing atrophy post-eradication, PPIs can intensify corporal gastritis.
Conclusions:
- Advancements in chronic gastritis diagnostics and treatment are crucial for developing effective gastric cancer prevention strategies.
- Standardized classifications and non-invasive diagnostics improve patient management and research.
- Understanding the interplay between H. pylori, PPIs, and gastritis progression is key for future interventions.
More Related Videos
03:48Effects of Desmodium caudatum on Gastrointestinal Hormones and Intestinal Flora in Rats with Gastritis
Published on: March 1, 2024
03:05Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia
Published on: February 16, 2024
Related Concept Videos
01:27Gastritis-I: Introduction and Types
Gastritis, defined by the inflammation or irritation of the stomach lining or gastric mucosa, manifests in several distinct forms: acute, chronic, reactive, and a specific subtype known as autoimmune metaplastic atrophic gastritis.
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
01:17Gastritis-II: Pathophysiology
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
01:23Gastritis III: Clinical Manifestations and Management
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
01:26Peptic Ulcer Disease IV: Management
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
01:26Gastritis II: Pathophysiology
The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
01:25Peptic Ulcer Disease III: Clinical Manifestations and Complications
Duodenal UlcersDuodenal ulcers are the most common form of peptic ulcer disease, presenting with chronic, intermittent epigastric pain. Pain typically appears 2–3 hours after meals, especially when the stomach is empty, often waking patients at night. It is characteristically relieved by food or antacids (“pain–food–relief”). Some patients remain asymptomatic until complications like bleeding or perforation emerge, particularly with NSAID or anticoagulant use.Gastric UlcersGastric ulcers share...